West Virginia · 2026

HB 4626

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Bill record: Open States bulk CSV (bills/votes) ocd-bill/b421b74e-88fb-41e2-9a9b-a1355a9aeabf CC0-1.0

Summary AI-generated

West Virginia House Bill 4626 proposes establishing a grant program to fund drug development trials conducted by the United States Food and Drug Administration using ibogaine.

Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)

Issue tags AI-classified

Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)

Sponsors + 6 cosponsors

Roll-call votes on this bill

Motion / questionChamberStageRollOutcomeYeaNayOtherDateSource
Passage upper 05617ca7-1f0b-4e76-acab-19d184f55ef5 pass 33 0 0 Mar 12, 2026 Open States bulk CSV (bills/votes) ocd-vote/05617ca7-1f0b-4e76-acab-19d184f55ef5 CC0-1.0
PASSAGE lower 92341ed7-7afc-4fa5-86bd-60e66c9629fd pass 95 0 3 Jan 29, 2026 Open States bulk CSV (bills/votes) ocd-vote/92341ed7-7afc-4fa5-86bd-60e66c9629fd CC0-1.0